Prostate Cancer Clinical Trials

Showing 61-80 of 2,150 trials

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

NCT00859781

The purpose of this study is to test the effectiveness of the experimental drug, 177Lu-J591 in combination with ketoconazole and hydrocortisone against prostate cancer.

Prostate Cancer

Weill Medical College of Cornell University55 participantsStarted Jun 2009

Los Angeles, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +6 more locations

RECRUITINGNA

Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

NCT02706561

The purpose of this study is to test two different ways to help men with sexual rehabilitation.

Prostate CancerErectile Dysfunction

Memorial Sloan Kettering Cancer Center224 participantsStarted Dec 2015

New York, New York, United States

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

Related Searches

External Beam and Radioligand Radiotherapy for mCRPC

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC

A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer

Evaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer

Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST).

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)

GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

Quality of Life in Prostate Cancer Patients

AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs